Literature DB >> 17952135

Lipopolysaccharide-induced cerebral inflammatory damage and the therapeutic effect of platelet activating factor receptor antagonist.

Wen-Chao Liu1, Wen-Long Ding, Hong-Yu Gu, Ming-Feng Chen, Jin-Jia Hu.   

Abstract

OBJECTIVE: To investigate lipopolysaccharide (LPS) induced acute cerebral inflammatory damage and the therapeutic effect of ginkgolide B (BN52021).
METHODS: Thirty Sprague-Dawley rats were randomly divided into 3 groups (n = 10 for each group): Control group, Model group and Treatment group (treated with BN52021). LPS were injected into the fourth ventricle of rat to make a neuroinflammatory murine model. Morris water maze was used to detect the learning and memory ability of rats; changes of synapse number and subcellular ultrastructures were observed under a transmission electron microscope; OX-42 positive microglia in the brain was detected by immunohistochemical method.
RESULTS: The average escape latency in the Treatment group were significantly shortened than that in the Model group; and the percentage of swimming distance traveled in platform quadrant accounting for total distance increased markedly. The rough endoplasmic reticulum and polyribosomes in the Treatment group were more than that in the Model group, but the number of synapses seemed to have no obvious change. The number of OX-42 positive microglia in the Treatment group decreased markedly than that in the Model group, and the grey density of OX-42-positive cells increased significantly.
CONCLUSION: LPS can induce inflammatory damages to the brain, but the damage could be antagonized by BN52021. Platelet activating factor receptor antagonist may offer an effective therapy for neurodegeneration diseases.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17952135      PMCID: PMC5550574          DOI: 10.1007/s12264-007-0040-z

Source DB:  PubMed          Journal:  Neurosci Bull        ISSN: 1995-8218            Impact factor:   5.203


  12 in total

1.  Behavioral and ultrastructural changes induced by chronic neuroinflammation in young rats.

Authors:  B Hauss-Wegrzyniak; M G Vannucchi; G L Wenk
Journal:  Brain Res       Date:  2000-03-17       Impact factor: 3.252

2.  Gene expression changes by amyloid beta peptide-stimulated human postmortem brain microglia identify activation of multiple inflammatory processes.

Authors:  Douglas G Walker; John Link; Lih-Fen Lue; Jessica E Dalsing-Hernandez; Barry E Boyes
Journal:  J Leukoc Biol       Date:  2005-12-19       Impact factor: 4.962

3.  Influence of premorbid IQ and education on progression of Alzheimer's disease.

Authors:  V N Pavlik; R S Doody; P J Massman; W Chan
Journal:  Dement Geriatr Cogn Disord       Date:  2006-09-05       Impact factor: 2.959

4.  Disturbance of oligodendrocyte development, hypomyelination and white matter injury in the neonatal rat brain after intracerebral injection of lipopolysaccharide.

Authors:  Yi Pang; Zhengwei Cai; Philip G Rhodes
Journal:  Brain Res Dev Brain Res       Date:  2003-02-16

Review 5.  Activity of flurbiprofen and chemically related anti-inflammatory drugs in models of Alzheimer's disease.

Authors:  Laura Gasparini; Ennio Ongini; Donna Wilcock; David Morgan
Journal:  Brain Res Brain Res Rev       Date:  2005-01-28

6.  LPS receptor (CD14): a receptor for phagocytosis of Alzheimer's amyloid peptide.

Authors:  Yang Liu; Silke Walter; Massimiliano Stagi; Dmitry Cherny; Maryse Letiembre; Walter Schulz-Schaeffer; Holger Heine; Botond Penke; Harald Neumann; Klaus Fassbender
Journal:  Brain       Date:  2005-04-27       Impact factor: 13.501

7.  Impaired spatial cognition and synaptic potentiation in a murine model of human immunodeficiency virus type 1 encephalitis.

Authors:  Walter E Zink; Eric Anderson; Jeffrey Boyle; Lynette Hock; Jorge Rodriguez-Sierra; Huangui Xiong; Howard E Gendelman; Yuri Persidsky
Journal:  J Neurosci       Date:  2002-03-15       Impact factor: 6.167

8.  Brain inflammatory response induced by intracerebroventricular infusion of lipopolysaccharide: an immunohistochemical study.

Authors:  B Hauss-Wegrzyniak; L Lukovic; M Bigaud; M E Stoeckel
Journal:  Brain Res       Date:  1998-06-01       Impact factor: 3.252

9.  Inhibition of hippocampal LTP by ginkgolide B is mediated by its blocking action on PAF rather than glycine receptors.

Authors:  Elena L Kondratskaya; Yuri V Pankratov; Ulyana V Lalo; Shyam S Chatterjee; Oleg A Krishtal
Journal:  Neurochem Int       Date:  2004-02       Impact factor: 3.921

10.  Binding of platelet-activating factor to platelets of Alzheimer's disease and multiinfarct dementia patients.

Authors:  M Hershkowitz; A Adunsky
Journal:  Neurobiol Aging       Date:  1996 Nov-Dec       Impact factor: 4.673

View more
  5 in total

1.  Chronic Neuroinflammation Induced by Lipopolysaccharide Injection into the Third Ventricle Induces Behavioral Changes.

Authors:  Shufang Na; Xuejiao Duan; Rongyan Wang; Yanjie Fan; Ke Xue; Shuwei Tian; Zheqiong Yang; Ke Li; Jiang Yue
Journal:  J Mol Neurosci       Date:  2021-01-06       Impact factor: 3.444

2.  BN52021 protects rat cardiomyocyte from doxorubicin induced cardiotoxicity.

Authors:  Wen Yan; Chengluan Xuan; Lei Xuan; Rihao Xu; Junnan Wang
Journal:  Int J Clin Exp Pathol       Date:  2015-02-01

3.  Effect of doxycycline and meloxicam on cytokines, brain-derived neurotrophic factor, matrix metalloproteinase-3, tissue inhibitor of metalloproteinase-3 and cyclooxygenase-2 in brain.

Authors:  Ayse Er; Devran Coskun; Emre Bahcivan; Burak Dik
Journal:  Iran J Basic Med Sci       Date:  2020-10       Impact factor: 2.699

4.  Hydrogen sulfide protects against amyloid beta-peptide induced neuronal injury via attenuating inflammatory responses in a rat model.

Authors:  Hao Fan; Yu Guo; Xiaoyan Liang; Yibiao Yuan; Xiaohong Qi; Min Wang; Jianhua Ma; Hong Zhou
Journal:  J Biomed Res       Date:  2013-06-10

5.  Platelet Activating Factor Enhances Synaptic Vesicle Exocytosis Via PKC, Elevated Intracellular Calcium, and Modulation of Synapsin 1 Dynamics and Phosphorylation.

Authors:  Jennetta W Hammond; Shao-Ming Lu; Harris A Gelbard
Journal:  Front Cell Neurosci       Date:  2016-01-08       Impact factor: 5.505

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.